Circulating ESR1 mutation detection rate and early decrease under first line aromatase inhibitor and palbociclib in the PADA-1 trial (UCBG-GINECO)

Affiliation auteurs!!!! Error affiliation !!!!
TitreCirculating ESR1 mutation detection rate and early decrease under first line aromatase inhibitor and palbociclib in the PADA-1 trial (UCBG-GINECO)
Type de publicationJournal Article
Year of Publication2019
AuteursBidard F-C, Pistilli B., Dalenc F., T. Rouge DLa Motte, Sabatier R., Frenel J-S, Ladoire S., Dubot C., Ferrero J-M, Levy C., Lortholary A., Stefani L., Mouret-Reynier M-A, Hardy A-C, Jacquin J-P, Grenier J., Chakiba C., Teixeira L., Soulie P., Everhard S., Lemonnier J., Jeannot E., Bieche I., Berger F., Pierga J-Y, Bachelot T., Delaloge S.
JournalCANCER RESEARCH
Volume79
Date PublishedFEB
Type of ArticleMeeting Abstract
ISSN0008-5472
DOI10.1158/1538-7445.SABCS18-PD2-06